Pharmaceutical Technology

JULY 2, 2025

Robert Barrie July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Yeztugo, injected twice a year, offers more convenient dosing than daily pills. The US Food and Drug Administration (FDA) approved Yeztugo last month , bringing a more convenient PrEP option for adults and adolescents at risk of HIV exposure.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Packaging Communication Hospitals 52

Pharmaceutical Technology

JUNE 11, 2025

Robert Barrie June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Gilead said it is “committed to working with regulatory authorities to resolve the issues underlying the clinical hold” Credit: Melnikov Dmitriy via Shutterstock. Gilead is considered the leading big pharma in HIV treatments.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Communication Hospitals Packaging 52

Putting Patients First Blog

NOVEMBER 12, 2024

Recognizing PrEP as a preventive service rather than as indicative of an active medical condition, as HHS proposes, could help address the current risk selection seen in the market. Clear guidance on the treatment of rebates within the ACF will help avoid distortions in pricing and prevent patients from bearing disproportionate costs.

Insurance Coverage and Processing 52

Insurance Coverage and Processing HIV Treatment and Prevention Agents Communication Hospitals 52

ID Stewardship

DECEMBER 11, 2024

With Twitter changing to X in mid-2023 and subsequently in the end of 2024 many folks from the IDtwitter community moving over to Bluesky, the game is certainly ever-changing. I wonder if this will cause us to be more fragmented as a group in 2025 and if Bluesky will really have sticking power. Mastodon sure did not.

HIV Treatment and Prevention Agents 145

HIV Treatment and Prevention Agents Labelling Hospitals Communication 145